VEGF nanoparticles repair the heart after myocardial infarction. [electronic resource]
Producer: 20190114Description: H278-H284 p. digitalISSN:- 1522-1539
- Angiogenesis Inducing Agents -- administration & dosage
- Animals
- Cells, Cultured
- Delayed-Action Preparations
- Disease Models, Animal
- Drug Carriers
- Drug Compounding
- Human Umbilical Vein Endothelial Cells -- drug effects
- Humans
- Mice, Inbred NOD
- Mice, SCID
- Myocardial Contraction -- drug effects
- Myocardial Infarction -- drug therapy
- Nanoparticles
- Neovascularization, Physiologic -- drug effects
- Polylactic Acid-Polyglycolic Acid Copolymer -- chemistry
- Recovery of Function
- Time Factors
- Vascular Endothelial Growth Factor A -- administration & dosage
- Ventricular Function, Left -- drug effects
- Ventricular Remodeling -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.